LBA82 Influenza-like illness and SARS-Cov-2 in the multicenter, prospective, observational INVIDIa-2 study (INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: A transversal challenge): A FICOG study.

Saved in:
Bibliographic Details
Title: LBA82 Influenza-like illness and SARS-Cov-2 in the multicenter, prospective, observational INVIDIa-2 study (INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: A transversal challenge): A FICOG study.
Authors: Bersanelli, M.1 (AUTHOR), Giannarelli, D.2 (AUTHOR), Verzoni, E.3 (AUTHOR), Buti, S.4 (AUTHOR), De Giorgi, U.5 (AUTHOR), Clemente, A.6 (AUTHOR), Filetti, M.7 (AUTHOR), Di Napoli, M.8 (AUTHOR), Calvetti, L.9 (AUTHOR), Ermacora, P.10 (AUTHOR), Catino, A.M.11 (AUTHOR), Guaitoli, G.12 (AUTHOR), Bonomo, P.13 (AUTHOR), Mazzoni, F.14 (AUTHOR), Veccia, A.15 (AUTHOR), Grosso, F.16 (AUTHOR), Maruzzo, M.17 (AUTHOR), Rossi, E.18 (AUTHOR), Grossi, F.19 (AUTHOR), Procopio, G.20 (AUTHOR)
Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS1209-S1209. 1p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2020.08.2323